SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-16-001326
Filing Date
2016-07-07
Accepted
2016-07-07 16:19:01
Documents
3
Group Members
ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss1727_sc13d.htm SC 13D 164603
2 JOINT FILING AGREEMENT ss1727_ex9901.htm EX-99.1 20817
3 FORM OF LOCK-UP LETTER AGREEMENT ss1727_ex9902.htm EX-99.2 41819
  Complete submission text file 0000947871-16-001326.txt   228810
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 480 ARSENAL STREET BUILDING ONE WATERTOWN MA 02472
Business Address 480 ARSENAL STREET BUILDING ONE WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Subject) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89550 | Film No.: 161756787
SIC: 2834 Pharmaceutical Preparations